Journal of Antimicrobial Chemotherapy, Vol 39, 331-337, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
PD Midolo, JD Turnidge and JR Lambert
The bactericidal activity of the proton pump inhibitors omeprazole and
lansoprazole alone and in combination with a beta-lactam or macrolide
antibiotic were investigated in vitro. Time-kill curves against
Helicobacter pylori NCTC 11637 and a recent clinical isolate revealed
significant concentration-dependent killing with all drugs other than
amoxycillin. Combinations of proton pump inhibitor and erythromycin showed
synergic activity. In contrast, proton pump inhibitor plus amoxycillin
showed additive activity against the clinical isolate only. Bactericidal
investigations of anti-helicobacter drugs in vitro may suggest optimum
treatment strategies for this common infectious disease.
JOURNAL ARTICLE
Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro
Department of Microbiology and Infectious Diseases, Monash Medical Centre, Clayton, Victoria, Australia.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Afeltra, R. G. Vitale, J. W. Mouton, and P. E. Verweij Potent Synergistic In Vitro Interaction between Nonantimicrobial Membrane-Active Compounds and Itraconazole against Clinical Isolates of Aspergillus fumigatus Resistant to Itraconazole Antimicrob. Agents Chemother., April 1, 2004; 48(4): 1335 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lozniewski, A. Duprez, C. Renault, F. Muhale, M.-C. Conroy, M. Weber, A. Le Faou, and F. Jehl Gastric Penetration of Amoxicillin in a Human Helicobacter pylori-Infected Xenograft Model Antimicrob. Agents Chemother., August 1, 1999; 43(8): 1909 - 1913. [Abstract] [Full Text] |
||||
